BiotechTube
Home/Vaderis Therapeutics/Azmi Nabulsi, MD, MPH
AN

Azmi Nabulsi, MD, MPH

President & CEO

Vaderis Therapeutics

Therapeutic Areas

Rare Vascular DiseasesHereditary Hemorrhagic Telangiectasia (HHT)

Vaderis Therapeutics Pipeline

DrugIndicationPhase
EngasertibHereditary Hemorrhagic Telangiectasia (HHT)Pre-clinical

Leadership Team at Vaderis Therapeutics

DP
Damien Picard, MD, PhD
Senior Medical Director & Co-Founder
PS
Pierre Saint-Mezard, PhD, MBA
Chief Scientific Officer & Co-Founder
DS
Darryl Sleep, MD
Chief Medical Officer
TH
Tom Harris
Chief Operating & Development Officer
View full Vaderis Therapeutics profile